CAS: 19169-90-5; Bromomethylphenylsulfone

该化合物是一种多用途的全氟辛烷磺酸衍生物,广泛用作有机合成的中间体,特别是在制药和农用化学应用中.其主要优势包括作为烷基剂的活性,能够将苯磺酰甲基组引入目标分子中.该化合物的稳定性和定义明确的再活性剖面使其适合受控变异,如核生殖替代或交叉反应.它还因其在构建复杂的分子结构,包括外转循环和功能化的全氟辛烷磺酸方面的作用而备受重视.该产品通常在标准实验室条件下处理,尽管其溴甲基组需要谨慎储存以避免降解.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

ethanol ((dibromomethyl)sulfonyl)benzene sodium ethanolate benzenesulfonylacetic acid1-phenylsulphonyl-3-methyl butane phenyl pentyl sulfone nonyl phenyl sulphone ((cyclohexylmethyl)sulfonyl)benzene

合成工艺路线路线简述

    苯甲砜置于lithium Hexamethyldisilazane,溴体系中,用 1,4-二氧六环 用作溶剂,化学反应 3.5H,以56%的收率获得溴甲基苯基砜
    参考文献:使用试剂-溶剂卤素键控制烷基砜的α-单-和α,α-二-卤代反应†
    标题:使用试剂-溶剂卤素键控制烷基砜的α-单-和α,α-二-卤代反应†
    摘要:烷基砜的直接和选择性α-单溴化是通过碱介导的亲电子卤化作用实现的.发现溶剂和亲电子溴源的适当组合对于控制所形成产品的性质至关重要,在此,提出了通过改变亲电子溴源的有效尺寸来控制试剂-溶剂卤素键来控制选择性的方法.相反,多卤化后,在后处理过程中进行选择性脱卤后,以高收率选择性地获得了α,α-二溴代砜.两种方法都可以以克为单位进行应用,并且单卤化成功地扩展到烷基砜的全选择性α-氯化,α-碘化和α-氟化.
    Doi:10.1039/c9Cc00550A

    海关参考信息

    专利信息


    专利号:US-9556140-B2
    优先权日:2013-01-26
    标 题 :Approach for synthesis of catechins
    发明人:DUGAR SUNDEEP; MAHAJAN DINESH; RAI KUMAR SANTOSH; TRIPATHI VINAYAK; PATIL ISHWAR RAKESH
    权利人:SPHAERA PHARMA PRIVATE LTD
    摘要:A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+ and/or −) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-protected quercetin obtained from step (i); (iii) optionally deprotecting the compound of step (ii); (iv) reducing the compound obtained from step (ii) or step (iii) in the presence of a chiral/achiral reducing agent to obtain a chiral intermediate; (v) deprotecting and/or hydrogenation of the chiral intermediate obtained from step (iv) to obtain (−)-epicatechin; (vi) optionally simultaneously deprotecting and by drogenation of the compound obtained from step (ii) to obtain racemic epicatechin.

    专利号:US-6455680-B1
    优先权日:2000-12-21
    标 题 :Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
    发明人:LUKIN KIRILL A
    权利人:ABBOTT LAB
    摘要:An efficient deoximation technique for use in synthesis of erythromycin derivatives, involving aryl thioimine intermediates is disclosed. The aryl thioimine intermediates can be utilized in a method for protecting a ketone of a ketone-containing erythromycin derivative as a thioimine; a method for deoximating an oxime-containing erythromycin derivative, or a method for preparing a 6-O-alkyl erythromycin derivative. Presently preferred erythromycin derivatives have a C-9 oxime or a C-9 ketone.

    专利号:US-9428482-B2
    优先权日:2011-01-27
    标 题 :Process for synthesis of polyphenols
    发明人:DUGAR SUNDEEP; MAHAJAN DINESH; PANTELIS PETER GIANNOUSIS; SINGH VIJAY; KAPOOR KAMAL KISHORE
    权利人:DUGAR SUNDEEP; MAHAJAN DINESH; PANTELIS PETER GIANNOUSIS; SINGH VIJAY; KAPOOR KAMAL KISHORE; SPHAERA PHARMA PTE LTD
    摘要:The present invention provides synthetic processes for preparing racemic and/or optically pure epicatechin, epigallocatechin and related polyphenols as such or as their variously functionalized derivatives. A principle objective of the disclosure is to provide a new and useful method of synthesis to obtain polyphenols in isomerically pure and/or racemic forms.

    专利号:JP-2020117531-A
    优先权日:2013-01-26
    标题 :Novel process for synthesis of catechins

    专利号:US-2014031421-A1
    优先权日:2011-01-27
    标 题 :Novel process for synthesis of polyphenols

    专利号:US-2015368223-A1
    优先权日:2013-01-26
    标 题 :Novel approach for synthesis of catechins
    南通嘉星泰生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jxtbio.com
    企业联系电话:18795782766;13773776703👤
    📞南通嘉星泰生物科技有限公司 ⚠️参考联系方式
    联系人:蔡先生
    电话:18795782766;13773776703

    传真:0513-87503981
    邮箱:297962169@qq.com
    通信地址: 江苏省如皋市石庄镇张扬园村十组42号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省如皋市石庄镇张扬园村十组42号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知